Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics

Na Li,Yun-He Liu,Ji Wu,Qiu-Ge Liu,Jin-Bo Niu,Yan Zhang,Xiang-Jing Fu,Jian Song,Sai-Yang Zhang

DOI: https://doi.org/10.1016/j.ejmech.2024.116694

IF: 7.088

2024-07-26

European Journal of Medicinal Chemistry

Abstract:As a highly conserved signaling network across different species, the Hippo pathway is involved in various biological processes. Dysregulation of the Hippo pathway could lead to a wide range of diseases, particularly cancers. Extensive researches have demonstrated the close association between dysregulated Hippo signaling and tumorigenesis as well as tumor progression. Consequently, targeting the Hippo pathway has emerged as a promising strategy for cancer treatment. In fact, there has been an increasing number of reports on small molecules that target the Hippo pathway, exhibiting therapeutic potential as anticancer agents. Importantly, some of Hippo signaling pathway inhibitors have been approved for the clinical trials. In this work, we try to provide an overview of the core components and signal transduction mechanisms of the Hippo signaling pathway. Furthermore, we also analyze the relationship between Hippo signaling pathway and cancers, as well as summarize the small molecules with proven anti-tumor effects in clinical trials or reported in literatures. Additionally, we discuss the anti-tumor potency and structure-activity relationship of the small molecule compounds, providing a valuable insight for further development of anticancer agents against this pathway.

chemistry, medicinal